Satellite Symposia


There are 9 interesting satellite symposia sponsored by our industrial partners, who chose the topics and speakers.

Wednesday, 16.11.2022

12:15 - 1:15 p.m.

AbbVie AG
Get REAL! Swiss data on Venetoclax
Real-world evidence in R/R CLL and AML 1L unfit

12:15 - 1:15 p.m.

Janssen-Cilag AG
Breakthrough Therapies: Targeting BCMA in Multiple Myeloma

12:15 - 1:15 p.m.

Gilead Sciences Switzerland Sàrl

 

Thursday, 17.11.2022

12:15 - 1:15 p.m.

Incyte Biosciences International Sàrl & Servier (Suisse) S.A.
Precision Medicine in Cholangiocarcinoma

12:15 - 1:15 p.m.

GSK
Challenges and advances in the treatment of relapsed/refractory Multiple Myeloma

12:15 - 1:15 p.m.

Astellas Pharma AG
Clinical value of biomarkers in Gastric and GEJ Cancers

 

Friday, 18.11.2022

12:15 - 1:15 p.m.

Novartis Pharma Schweiz AG
How I Treat: Considerations in clinical practice for Non-Hodgkin Lymphomas (NHL)
and Chronic myelogenous leukemia (CML)

12:15 - 1:15 p.m.

Roche Pharma (Schweiz) AG
Bispecifics and Beyond: Innovation in Hematology made in Basel

12:15 - 1:15 p.m.

Takeda Pharma AG
Treatment of advanced Hodgkin Lymphoma – How can we do better?

 

Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.